Partner Product Offerings: Millipore Sigma| Bio-Rad | R&D Systems|Thermo Fisher Scientific

There are currently more than 60 Luminex Licensed Technologies Partners worldwide that provide kits, assay development, and testing services for the research and diagnostic markets. While you can find more than 1,400 commercially available multiplex immunoassays in the xMAP® Kit Finder, below is a selection of the newest products and services. Millipore Sigma Bio-Rad R&D […]

Read More…

Partner Product Offerings: Affymetrix | R&D Systems | EMD Millipore | Luminex

Affymetrix

Checkmate on Cancer – get the full view soluble immune checkpoint molecules

 
ProcartaPlex® Immuno-Oncology Checkpoint Molecules Panel (14 plex)

The Immuno-Oncology Checkpoint Marker Panel is the first commercially available, multiplex immunoassay system that allows the simultaneous detection of the soluble forms of the following 14 checkpoint modulators…

R&D Systems, a Bio-Techne Brand

Want at custom biomarker assay? Don’t want to build it yourself?

The Luminex® Assay, by R&D Systems, offers 347 biomarkers to select from enabling you to configure the exact assay you need. This near custom assays solution is optimized to deliver the most flexible Luminex Assay available…

EMD Millipore

MILLIPLEX® MAP Human Neuroscience Magnetic Bead Panel 1

Researching Parkinson’s Disease, Alzheimer’s Disease, or Traumatic Brain Injury?

The MILLIPLEX® MAP Human Neuroscience Magnetic Bead Panel 1 (product number HNS1MAG-95K) is a new 6-plex kit that requires only 25μL of neat human cerebrospinal fluid (CSF) per assay…

[…]

Read More…

Bitten by the Tropical Medicine Bug

Developing multiplex assays and surveillance systems for neglected tropical diseases In 1995, Satoshi Kaneko was a practicing surgeon in Tokyo until he was invited by a colleague to join the Japan International Cooperation Agency in Guatemala to support a Chagas disease project. While he was not bitten by the kissing bug that transmits Chagas, he […]

Read More…

Tackling S. pneumoniae: Why Multiplexing Matters

Discriminating 93 serotypes takes a lot of beads Ger Rijkers and the Pneumococcal Consortium are working to develop standardized multiplex assays for S. pneumoniae antibodies. For this project, Rijkers, Head of the Department of Science at University College Roosevelt in The Netherlands, is designing a custom multiplex assay to efficiently identify the 93 antibodies against […]

Read More…

Adopting DigiWest®: How a Multiplex Immunoassay Is Making a Difference in Precision Oncology

Test replaced LDT, offering better ease of use and more comprehensive targets At CPO (Cellular Phenomics & Oncology), a Berlin-based company specializing in cellular phenomics and oncology, scientists are making significant progress in precision oncology by combining patient-derived, three-dimensional cell culture models with Luminex-based DigiWest® technology. The resulting data from this approach can inform the […]

Read More…

Five Things We Learned from an xMAP® Power User

DKFZ’s Tim Waterboer has published more xMAP papers than any other user At the fourth annual xMAP® Connect user group meeting held in Amsterdam late last year, we had the good fortune of sitting down with Tim Waterboer, PhD, leader of the Infections and Cancer Epidemiology Group at DKFZ, the German Cancer Research Center. Waterboer […]

Read More…

Can’t Get Out of the Lab? No Travel Budget Left This Year? Not a Problem!

Check out these digital resources: xMAP® partner webinars, virtual conferences, and how-to videos  Luminex Partner Sponsored Webinars How to Non-Invasively Monitor Stem Cell Differentiation Using Luminex® Technology Richard Fuerstenberg, Manager of Multiplex Development, R&D Systems Joy Aho, Manager of Stem Cell Research and Development, R&D Systems http://bit.ly/Bio-TechneWebinars  Cross-validation of Antibodies Using DigiWest Anthony Couvillon, PhD, […]

Read More…

Demystifying the Immune Response

Developing tools to aid in the development of vaccines and therapeutic antibodies Our understanding of the immune system has significantly progressed since Edward Jenner published his work in 1798 describing the development of the first vaccine. Jenner recognized that dairymaids previously infected with cowpox were immune to smallpox. To test his hypothesis, Jenner infected a […]

Read More…

Prime Diagnostics: Custom Agricultural Assay Solutions

Enabling plant pathogen detection to boost the global food supply Jan Bergervoet wants to maximize the global food supply. Not only has he developed numerous assays for the detection of plant pathogens, but Bergervoet has also pioneered statistical methods to set mathematically derived thresholds of sample positivity. Bergervoet has been a member of the Plant […]

Read More…